Imagen de Portada

Setmelanotide in Bardet‐Biedl Syndrome: A 52‐Week Comparison of Phase 3 Trial Participants With a Matched Registry Cohort

Fuente: Wiley Open Access

Guardado en:

Detalles Bibliográficos
Autores principales:	Jesús Argente, Andrea M. Haqq, Jan Luca Schorfheide, Nicolas Touchot, Caroline Huber, Urs Wiedemann, Jeremy Pomeroy
Formato:	Artículo Open Access
Publicado:	Wiley 2026
Materias:	Obesity
Acceso en línea:	Acceder al recurso
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares

Correction to “Setmelanotide in Bardet‐Biedl Syndrome: A 52‐Week Comparison of Phase 3 Trial Participants With a Matched Registry Cohort”
Publicado: (2026)

Hyperphagia in Bardet–Biedl syndrome: Pathophysiology, burden, and management
por: Philip L. Beales, et al.
Publicado: (2025)

Clinical burden of hyperphagia, obesity and health outcomes in paediatric individuals with Bardet‐Biedl syndrome: A CRIBBS data analysis
por: Jeremy Pomeroy, et al.
Publicado: (2025)

Bardet‐Biedl syndrome: A focus on genetics, mechanisms and metabolic dysfunction
por: Jeremy W. Tomlinson
Publicado: (2024)

Bardet‐Biedl syndrome: A clinical overview focusing on diagnosis, outcomes and best‐practice management
por: Ashley Shoemaker
Publicado: (2024)

Effectiveness and Safety of Setmelanotide in a Patient With a Heterozygous PCSK1 Deficiency
por: Ellina Lytvyak, et al.
Publicado: (2026)

Weekly Subcutaneous VK2735 , a GIP / GLP ‐1 Receptor Dual Agonist, for Weight Management: Phase 2, Randomized, 13‐Week VENTURE Study
por: Harold E. Bays, et al.
Publicado: (2026)

Association of Tirzepatide With Kidney Parameters in Participants With Obesity and Prediabetes From SURMOUNT ‐1 Over 176 Weeks
por: Hiddo J. L. Heerspink, et al.
Publicado: (2026)

Effect of Sevelamer and B. longum on Insulin Sensitivity in Participants With Obesity: A Randomized Clinical Trial
por: Eric Baeuerle, et al.
Publicado: (2026)

Efficacy and Safety of Tirzepatide in Japanese Participants With Obesity: A Subpopulation Analysis of the SURMOUNT ‐1 Trial
por: Yasushi Ishigaki, et al.
Publicado: (2026)

Survodutide for the Treatment of Obesity Disease in Japanese Participants: Rationale, Design and Baseline Characteristics of the Phase 3 SYNCHRONIZE ‐ JP Trial
por: Koutaro Yokote, et al.
Publicado: (2026)

The Macroeconomic Cost of Obesity and Overweight in European Countries: A Systematic Review and Methodological Quality Analysis
por: Jaume Puig‐Junoy, et al.
Publicado: (2025)

Association Between Metabolic Syndrome and Incident Cervical Cancer: A Retrospective Cohort Study
por: Linjun Jiang, et al.
Publicado: (2025)

ObesityWeek ® 2025—Reflecting on an Exciting Time in Obesity Research and Treatment
por: Susan Z. Yanovski, et al.
Publicado: (2026)

Streamlining Diagnosis of Bardet–Biedl Syndrome: New Diagnostic Algorithm With Updated Criteria
por: Jeremy J. Pomeroy, et al.
Publicado: (2026)

Application of the Lancet Commission Criteria for the Diagnosis of Obesity to a Clinical Trials Population: The LEAP Trial
por: Faith Anne N. Heeren, et al.
Publicado: (2025)

Reliability of the original and brief versions of the Eating Disorder Examination in binge‐eating disorder
por: Janet A. Lydecker, et al.
Publicado: (2024)

The Supportive Effect of Acarbose to Orlistat in Weight Management—A Randomized, Double‐Blind, Multiarm Phase 2 Trial
por: Ulf Holmbäck, et al.
Publicado: (2025)

Association of Cardiovascular‐Kidney‐Syndrome and Brain Macrostructure and Microstructure Injury: A Prospective Cohort Study
por: Guanyu Niu, et al.
Publicado: (2026)

Efficacy and Safety of Once‐Weekly and Once‐Daily Basal Insulins in Type 1 Diabetes Mellitus: A Systematic Review and Network Meta‐Analysis of Clinical Trials
por: Ricardo Amaral, et al.
Publicado: (2026)

Correction to “Association of Cardiovascular‐Kidney‐Syndrome and Brain Macrostructure and Microstructure Injury: A Prospective Cohort Study”
Publicado: (2026)

Testing a Personalized Behavioral Weight Loss Approach Using Multifactor Prescriptions and Self‐Experimentation: 12‐Week mHealth Pilot Randomized Controlled Trial Results
por: Caitlin E. Martinez, et al.
Publicado: (2025)

Effectiveness of Telemedicine Prescribing and a Long‐Acting Obesity Medication Behavioral Program: A 24‐Week Single‐Arm Study
por: Leslie J. Heinberg, et al.
Publicado: (2025)

GLP‐1 RA Use and Weight Loss Among Patients in a Weight Navigation Program Versus Primary Care: A Matched Cohort Study
por: Dina H. Griauzde, et al.
Publicado: (2026)

Mindful eating and its relationship with body mass index, binge eating, anxiety and negative affect
por: Sheila Pintado-Cucarella
Publicado: (2016)

Improving the diagnosis of hyperphagia in melanocortin‐4 receptor pathway diseases
por: M. Jennifer Abuzzahab, et al.
Publicado: (2025)

Variation in ultra‐processed food consumption from 6 to 15 years, body weight and body composition at 15 years of age at The Pelotas 2004 Birth Cohort
por: Iná S. Santos, et al.
Publicado: (2024)

Negative Consequences of Removing GLP‐1 RA Obesity Coverage: A Cross‐Sectional Cohort Comparison Study
por: Jackson M. Francis, et al.
Publicado: (2026)

Trends in Use of Obesity Medications and Metabolic and Bariatric Surgery Among All of Us Participants From 2003 to 2023
por: Olajide A. Adekunle, et al.
Publicado: (2026)

Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Petrelintide for Weight Management: Two Randomized, Controlled Phase 1 Trials
por: Minna Brændholt Olsen, et al.
Publicado: (2026)

Discontinuation of SGLT2i After a Urogenital Infection: A Population‐Based Matched Cohort Study of Patients With Type 2 Diabetes
por: Christine Ljungberg, et al.
Publicado: (2026)

Cardiovascular Indexes and Oxidative Balance in Advanced Cardiovascular–Kidney–Metabolic Syndrome
por: Zhaoqi Yan, et al.
Publicado: (2025)

Effect of Metformin Treatment on Gonadotropin Levels in Women With Polycystic Ovary Syndrome: A Systematic Review and Meta‐Analysis of 51 Randomised Controlled Trials
por: Robert Krysiak, et al.
Publicado: (2026)

Diabetes screening outcomes in youth presenting for paediatric weight management: A report of the Paediatric Obesity Weight Evaluation Registry
por: Seema Kumar, et al.
Publicado: (2024)

Impact of Sleeve Gastrectomy Versus Intensive Lifestyle Modifications With Obesity Management Medications on BMI Trajectory and Target Attainment: A Prospective Matched Cohort Study
por: Maria Francesca Russo, et al.
Publicado: (2026)

Effects of Glucagon‐Like Peptide‐1 Receptor Agonists (Mono and Combination Therapy) on Energy Expenditure: A Scoping Review
por: Flavio T. Vieira, et al.
Publicado: (2026)

Determinants of Parents' and Adolescents' Motivation Before Pediatric Weight Management—Data From the STARKIDS Cohort
por: Anne Herschbach, et al.
Publicado: (2026)

Association of Weight Status and Quality of Life Through Childhood and Adolescence: Australian Longitudinal Cohort Analysis
por: Alison Hayes, et al.
Publicado: (2026)

Response to “Critical Appraisal of Health Care Resource Utilization and Health Care Costs Among Digital Weight Loss Intervention Participants and Nonparticipants”
por: Casey Tak, et al.
Publicado: (2025)

Simplified Switching to Once‐Weekly Insulin Icodec Without an Initial One‐Time Additional Dose Versus Once‐Daily Insulin Glargine U100 in Basal Insulin‐Treated Type 2 Diabetes ( ONWARDS 10): A Randomised Controlled Trial
por: Julio Rosenstock, et al.
Publicado: (2026)